Science & Enterprise subscription

Follow us on Twitter

  • Then "Day at the Races" https://t.co/9VT3sNFSZG
    about 13 hours ago
  • The Forward, America’s Leading Jewish News Organization, Goes All Digital. Third-generation subscriber here and wor… https://t.co/2CdgU2WLwR
    about 15 hours ago
  • Our friends at Statista reported on a survey on how the shutdown is affecting people in the U.S., this weekend's in… https://t.co/AbSCYqzGjI
    about 18 hours ago
  • New post on Science and Enterprise: Infographic – Americans Affected by Gov’t Shutdown https://t.co/6uC0lIaMIU #Science #Business
    about 18 hours ago
  • New contributed post on Science and Enterprise: https://t.co/XjQZgoAp3S Hands Off! Robots in Modern Medicine
    about 19 hours ago

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn
INSTAGRAM

RNA Meds Companies Partner on Human, Animal Vaccines

Synthetic Genomics Inc. and Arcturus Therapeutics Inc. are collaborating on longer-lasting and more robust RNA therapies and vaccines for humans and animals. . . . → Read More: RNA Meds Companies Partner on Human, Animal Vaccines

Artificial Beta Cells Shown to Produce Insulin as Needed

A biomedical engineering team developed artificial beta cells that in animal tests perform similar to natural cells in the pancreas to produce insulin as needed for controlling blood glucose levels. . . . → Read More: Artificial Beta Cells Shown to Produce Insulin as Needed

Fox Foundation, 23andMe in Large-Scale Parkinson’s Study

The Michael J. Fox Foundation and personal genetics company 23andMe are recruiting a large group of individuals with and without Parkinson’s disease to provide a more complete picture of the disorder. . . . → Read More: Fox Foundation, 23andMe in Large-Scale Parkinson’s Study

Novartis Acquires Nuclear Meds Developer in $3.9B Deal

Drug maker Novartis is purchasing a company that develops therapies and diagnostics using radio isotopes for neuroendocrine and other cancers. . . . → Read More: Novartis Acquires Nuclear Meds Developer in $3.9B Deal

Can You Set Up Shop In An Industry You Know Nothing About?

More often than not, you can learn all you need to know about any line of business. . . . → Read More: Can You Set Up Shop In An Industry You Know Nothing About?

Here’s What a Real Opioid Emergency Looks Like

Let’s be clear — the limited steps ordered by the president to reduce the numbers of people addicted to opioids don’t look anything like a response to an emergency. . . . → Read More: Here’s What a Real Opioid Emergency Looks Like

Project to Develop Universal Flu Vaccine

An initiative joining academic, private, and national labs is designing a vaccine that covers all influenza strains, with clinical studies expected to begin early next year. . . . → Read More: Project to Develop Universal Flu Vaccine

Validic Integrating Home Health Data for Clinical Care

An application is being developed for a health care system to integrate data from patients’ home medical devices into their electronic health records and clinical care plans. . . . → Read More: Validic Integrating Home Health Data for Clinical Care

Phone-Based Lupus Home Test Kit in Development

A home test kit using smartphone imaging is being created by biomedical engineers to detect kidney inflammation caused by lupus, an autoimmune disorder. . . . → Read More: Phone-Based Lupus Home Test Kit in Development

Blood-Thinning Drugs Linked with Lower Dementia Risk

People with irregular heart rhythms given anti-coagulation drugs to reduce their risk of stroke were also less likely to develop dementia than their counterparts not receiving blood-thinners. . . . → Read More: Blood-Thinning Drugs Linked with Lower Dementia Risk